Theralink Technologies Inc Receivables Turnover Ratio (OBMP), from the first quarter 2024 to the first quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Theralink Technologies Inc   (OBMP)
 

Theralink Technologies Inc Accounts Receivables Turnover Ratio from the first quarter 2024 to the first quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Theralink Technologies Inc 's ability to collect accounts receivable sequentially worsen to 13.67, indicating more challenging environment then in the third quarter 2023, but still, it is a far cry from any concerns. Theralink Technologies Inc 's Accounts Receivable average collection period in the Dec 31 2023 quarter, has increased to 27 days, from 17 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 444 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 3119 to 3198.

What is Receivable Turnover Ratio?
What is Theralink Technologies Inc Selling?


What is Receivable Turnover Ratio?





OBMP Receivables Turnover Ratio (Dec 31 2023)
I. Quarter
(Jun 30 2023)
III. Quarter
(Mar 31 2023)
II. Quarter
(Dec 31 2022)
I. Quarter
(Sep 30 2022)
IV. Quarter
Y / Y Receivable Change 42.51 % -57.86 % 14.09 % 88.7 % 70.39 %
Y / Y Revenue Change -72.5 % 23.28 % 770.7 % -29.98 % 9.43 %
Receivable Turnover Ratio (TTM) 13.67 21.55 17.74 14.36 17.62
OBMP's Total Ranking # 3198 # 3119 # 562 # 3119 #
Accounts Receivable average collection period days 27 17 21 25 21
Seq. Receivable Change 205.2 % -63.06 % -15.91 % 50.33 % -9.75 %
Seq. Revenue Change -58.53 % 19.24 % 207.06 % -81.88 % 85.87 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 150
Healthcare Sector # 445
Overall Market # 3198

Receivable Turnover Ratio Statistics
High Average Low
0.3 0.21 0
(Jun 30 2023)   (Dec 31 2017)






Financial Statements
Theralink Technologies Inc 's Accounts Receivable $ 0 Millions Visit OBMP's Balance sheet
Theralink Technologies Inc 's Sales TTM $ 1 Millions Visit OBMP's Income Statement
Sources of OBMP's Revenues Visit OBMP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OBMP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OBMP's Growth Rates OBMP's Roa OBMP's Inventory Turnover Ratio OBMP's Dividend Comparisons
OBMP's Profitability Ratios OBMP's Roi OBMP's Asset Turnover Ratio OBMP's Dividend Growth
OBMP's Valuation Ratios OBMP's Roe OBMP's Financial Strength Ratios OBMP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Adaptimmune Therapeutics Plc  29.72 $ 60.281  Millions$ 2.029  Millions
Invo Fertility Inc   27.97 $ 3.021  Millions$ 0.108  Millions
Onemednet Corporation  27.36 $ 1.040  Millions$ 0.038  Millions
Aesthetic Medical International Holdings Group Limited  26.71 $ 100.824  Millions$ 3.775  Millions
Hutchmed china Limited  26.54 $ 837.999  Millions$ 31.569  Millions
National Vision Holdings Inc   26.38 $ 2,126.468  Millions$ 80.611  Millions
Orchestra Biomed Holdings Inc   25.56 $ 2.760  Millions$ 0.108  Millions
Cv Sciences Inc   25.51 $ 15.085  Millions$ 0.591  Millions
Evotec Se  25.30 $ 875.197  Millions$ 34.597  Millions
Clearside Biomedical Inc   25.18 $ 8.226  Millions$ 0.327  Millions
Cano Health Inc   24.48 $ 3,137.757  Millions$ 128.172  Millions
Qiagen N v   24.37 $ 1,900.688  Millions$ 77.988  Millions
Plus Therapeutics Inc   24.29 $ 4.913  Millions$ 0.202  Millions
Inmed Pharmaceuticals Inc  22.64 $ 5.487  Millions$ 0.242  Millions
Lineage Cell Therapeutics Inc   22.09 $ 8.945  Millions$ 0.405  Millions
Agenus Inc  21.11 $ 156.314  Millions$ 7.406  Millions
Kymera Therapeutics Inc   20.96 $ 78.592  Millions$ 3.750  Millions
Vystar Corporation  20.75 $ 0.526  Millions$ 0.025  Millions
Editas Medicine Inc   20.64 $ 78.123  Millions$ 3.784  Millions
Cue Health Inc   20.01 $ 70.936  Millions$ 3.545  Millions
Quantum Biopharma Ltd   19.91 $ 4.556  Millions$ 0.229  Millions
Gyre Therapeutics Inc   19.70 $ 113.450  Millions$ 5.760  Millions
Innovage Holding Corp   19.58 $ 720.796  Millions$ 36.806  Millions
Jrsis Health Care Corp  19.27 $ 3.939  Millions$ 0.204  Millions
Kiniksa Pharmaceuticals International Plc  19.17 $ 270.259  Millions$ 14.095  Millions
Rosecliff Acquisition Corp I  19.08 $ 18.056  Millions$ 0.946  Millions
Palvella Therapeutics Inc   18.84 $ 42.810  Millions$ 2.273  Millions
U S Physical Therapy Inc  18.56 $ 487.150  Millions$ 26.251  Millions
Marizyme Inc   18.31 $ 0.646  Millions$ 0.035  Millions
Valneva Se  18.11 $ 172.159  Millions$ 9.509  Millions

Date modified: 2026-09-08T15:11:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.